Procter & Gamble Company (The) $PG Stock: Choreo LLC Decreases Position

Key Points

• Choreo LLC reduced its Procter & Gamble position by 5.3% in the third quarter, selling 6,396 shares and retaining 113,438 shares valued at approximately $16.5 million. Institutional investors collectively own 65.77% of PG.
• Procter & Gamble exceeded quarterly expectations, reporting $2.00 in EPS and $23.28 billion in revenue, with revenue up 4% year over year. The company also declared a quarterly dividend of $1.0885, representing a 2.7% annualized yield.
• Analyst sentiment remains favorable, with Wells Fargo, JPMorgan, and Morgan Stanley raising price targets and the stock receiving a consensus “Moderate Buy” rating with an average target of $170.57. However, insider selling, rising costs, and mixed ratings present potential headwinds.

Choreo LLC decreased its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 5.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 113,438 shares of the company's stock after selling 6,396 shares during the period. Choreo LLC's holdings in Procter & Gamble were worth $16,481,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. Baxter Bros Inc. acquired a new position in shares of Procter & Gamble in the second quarter worth $12,381,000. Empowered Funds LLC purchased a new stake in shares of Procter & Gamble in the second quarter valued at $53,549,000. Bank of America Corp DE acquired a new stake in shares of Procter & Gamble during the second quarter valued at $3,850,628,000. Capstone Capital Management Ltd acquired a new stake in shares of Procter & Gamble during the third quarter valued at $991,000. Finally, Rokos Capital Management LLP purchased a new stake in Procter & Gamble during the 1st quarter worth about $29,914,000. Hedge funds and other institutional investors own 65.77% of the company's stock.

Insider Activity at Procter & Gamble

In other news, CEO Shailesh Jejurikar sold 35,000 shares of the stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $163.09, for a total transaction of $5,708,150.00. Following the transaction, the chief executive officer directly owned 55,391 shares in the company, valued at $9,033,718.19. This represents a 38.72% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Marc Pritchard sold 4,030 shares of the stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $143.79, for a total transaction of $579,473.70. Following the transaction, the insider owned 187,001 shares in the company, valued at approximately $26,888,873.79. The trade was a 2.11% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 58,647 shares of company stock worth $9,268,508. Corporate insiders own 0.23% of the company's stock.

Analysts Set New Price Targets

Several brokerages recently weighed in on PG. Wells Fargo & Company boosted their target price on shares of Procter & Gamble from $164.00 to $180.00 and gave the company an "overweight" rating in a research note on Friday, October 23rd. JPMorgan Chase & Co. raised their price target on shares of Procter & Gamble from $162.00 to $180.00 and gave the stock an "overweight" rating in a research note on Friday, October 23rd. Morgan Stanley lifted their price target on shares of Procter & Gamble from $166.00 to $185.00 and gave the stock an "overweight" rating in a report on Friday, October 23rd. Bank of America cut their price objective on shares of Procter & Gamble from $170.00 to $166.00 and set a "buy" rating for the company in a research report on Friday, July 10th. Finally, Evercore raised shares of Procter & Gamble from an "in-line" rating to an "outperform" rating and set a $166.00 price objective on the stock in a research note on Tuesday, October 6th. Fifteen research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat.com, Procter & Gamble currently has a consensus rating of "Moderate Buy" and an average target price of $170.57.

Procter & Gamble Price Performance

PG stock opened at $160.48 on Friday. The stock has a market capitalization of $371.95 billion, a price-to-earnings ratio of 24.17, a price-to-earnings-growth ratio of 3.89 and a beta of 0.39. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $167.25. The stock's fifty day simple moving average is $149.62 and its 200-day simple moving average is $148.85.

Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating the consensus estimate of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The firm had revenue of $23.28 billion during the quarter, compared to analyst estimates of $22.80 billion. During the same period in the prior year, the firm posted $1.99 earnings per share. The business's quarterly revenue was up 4.0% compared to the same quarter last year. Equities research analysts expect that Procter & Gamble Company will post 6.99 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be issued a $1.0885 dividend. The ex-dividend date is Friday, October 23rd. This represents a $4.35 annualized dividend and a yield of 2.7%. Procter & Gamble's payout ratio is 65.51%.

Procter & Gamble News Roundup

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Quarterly beat supports the stock: P&G reported earnings of $2.00 per share versus the $1.89 consensus estimate, while revenue of $23.28 billion exceeded expectations. Sales increased 4% year over year, helping reinforce confidence in the company’s growth outlook. What Did Procter & Gamble's Latest Quarter Change for Its Stock?
• Positive Sentiment: Analyst upgrade adds support: Freedom Broker raised its rating on PG from “hold” to “buy,” signaling increased confidence in the company’s earnings durability and valuation potential. Freedom Broker upgrades Procter & Gamble to buy from hold
• Positive Sentiment: Revenue growth and dividend appeal remain key attractions: Organic sales rose 4%, with much of the gain coming from higher product volumes. P&G’s portfolio of leading brands and long dividend history continue to appeal to income-focused investors. Procter & Gamble is Accelerating Revenue Growth as its Costs are Rising
• Neutral Sentiment: New bond issuance highlights financing strategy: P&G tapped euro and dollar markets with fixed-rate notes, providing funding flexibility but also adding debt obligations. The issuance puts greater focus on the company’s balance sheet and already elevated valuation. Procter & Gamble Bond Sale Puts Its Pricey Valuation Narrative In Focus
• Negative Sentiment: Cost inflation and mixed ratings temper optimism: Rising commodity and operating costs could pressure margins, while DZ Bank downgraded PG from “strong-buy” to “hold.” ETF net selling also represents a modest technical headwind. How Is Procter & Gamble Handling Commodity Costs After Its Report?

Procter & Gamble Profile

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.